Acurx Pharmaceuticals
ACXP
ACXP
25 hedge funds and large institutions have $2.71M invested in Acurx Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 26 → 25 (-1)
11% less capital invested
Capital invested by funds: $3.05M → $2.71M (-$342K)
Holders
25
Holding in Top 10
–
Calls
$78K
Puts
$56K
Top Buyers
| 1 | +$45K | |
| 2 | +$30.7K | |
| 3 | +$30.4K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$22.8K |
| 5 |
BlackRock
New York
|
+$19.8K |
Top Sellers
| 1 | -$94.5K | |
| 2 | -$91.7K | |
| 3 | -$31.9K | |
| 4 |
Two Sigma Investments
New York
|
-$31.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$18.6K |